By-health Co., Ltd.
300146.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.94B
Close$
$17.19
73.5% upside
Current Fair Value
73.5% upsideUndervalued by 73.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $15.94 Billion |
|---|---|
| Enterprise Value | $15.62 Billion |
| Annual dividend | $0.45 |
| Dividend yield | 4.78% |
| Earnings per Share | $0.47 |
| Beta | 0.43 |
| Outstanding Shares | 1,691,677,031 |
Return
| Return on Equity | 6.32% |
|---|---|
| Return on Assets | 5.12% |
| Return on Invested Capital | 7.36% |
Valuation & Multiples
| P/E Ratio | 23.24 |
|---|---|
| PEG | 102.27 |
| Price to Sales | 3.3 |
| Price to Book Ratio | 1.65 |
| Enterprise Value to Revenue | 2.35 |
| Enterprise Value to EBIT | 19.08 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 24, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$1.83 B
Consensus analyst estimateNext Earnings Call
Expected Date
March 22, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About By-health Co., Ltd.
2,867 employees
CEO: Zhicheng Lin
By-health Co., Ltd. operates internationally as a producer and vendor of a diverse range of dietary supplements. Its comprehensive portfolio encompasses essential nutrients like proteins, vitamins, and minerals, in addition to specialize...